O2–090SAFETY AND TOLERABILITY OF XELOX AS AN ADJUVANT THERAPY FOR STAGE2/3 COLORECTAL CANCER IN A HIGH RISK OF RECURRENCEH Osawa,N Handa,H Goto,T MyojoANNALS OF ONCOLOGY(2013)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要